Frederike K. Engels

<i>CYP3A4*22</i> Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity

Anne‐Joy M. de Graan, Laure Elens, Jason A. Sprowl et al. · Clinical Cancer Research · 2013 · 100 citations · Full text

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Frederike K. Engels, Walter J. Loos, Jessica M. van der Bol et al. · Clinical Cancer Research · 2011 · 77 citations · Full text

Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel

Frederike K. Engels, Floris A. de Jong, Alex Sparreboom et al. · The Oncologist · 2007 · 73 citations · Full text

Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?

Floris A. de Jong, Frederike K. Engels, Ron H.J. Mathijssen et al. · Journal of Clinical Oncology · 2005 · 44 citations · Full text

Cancer Management, Pathology, Pharmacotherapy +19

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

Frederike K. Engels, Ron A. A. Mathôt, Walter J. Loos et al. · Cancer Biology & Therapy · 2006 · 39 citations · Full text